Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 2;14:E106.
doi: 10.5888/pcd14.160572.

Novel Methods and Data Sources for Surveillance of State-Level Diabetes and Prediabetes Prevalence

Free PMC article

Novel Methods and Data Sources for Surveillance of State-Level Diabetes and Prediabetes Prevalence

Russ Mardon et al. Prev Chronic Dis. .
Free PMC article


States bear substantial responsibility for addressing the rising rates of diabetes and prediabetes in the United States. However, accurate state-level estimates of diabetes and prediabetes prevalence that include undiagnosed cases have been impossible to produce with traditional sources of state-level data. Various new and nontraditional sources for estimating state-level prevalence are now available. These include surveys with expanded samples that can support state-level estimation in some states and administrative and clinical data from insurance claims and electronic health records. These sources pose methodologic challenges because they typically cover partial, sometimes nonrandom subpopulations; they do not always use the same measurements for all individuals; and they use different and limited sets of variables for case finding and adjustment. We present an approach for adjusting new and nontraditional data sources for diabetes surveillance that addresses these limitations, and we present the results of our proposed approach for 2 states (Alabama and California) as a proof of concept. The method reweights surveys and other data sources with population undercoverage to make them more representative of state populations, and it adjusts for nonrandom use of laboratory testing in clinically generated data sets. These enhanced diabetes and prediabetes prevalence estimates can be used to better understand the total burden of diabetes and prediabetes at the state level and to guide policies and programs designed to prevent and control these chronic diseases.

Similar articles

See all similar articles

Cited by 2 articles


    1. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med 2013;368(17):1613–24. Erratum in: N Engl J Med 2013;369(6):587. 10.1056/NEJMsa1213829 - DOI - PubMed
    1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36(4):1033–46. 10.2337/dc12-2625 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. National diabetes statistics report, 2014. Accessed July 10, 2017.
    1. Barker LE, Kirtland KA, Gregg EW, Geiss LS, Thompson TJ. Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt. Am J Prev Med 2011;40(4):434–9. 10.1016/j.amepre.2010.12.019 - DOI - PubMed
    1. Zhang X, Geiss LS, Cheng YJ, Beckles GL, Gregg EW, Kahn HS. The missed patient with diabetes: how access to health care affects the detection of diabetes. Diabetes Care 2008;31(9):1748–53. 10.2337/dc08-0527 - DOI - PMC - PubMed

Publication types